Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 14, 2020

SELL
$4.29 - $5.64 $48,665 - $63,980
-11,344 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$4.87 - $7.08 $2,435 - $3,540
500 Added 4.61%
11,344 $57,000
Q2 2019

Aug 14, 2019

BUY
$6.6 - $7.8 $71,570 - $84,583
10,844 New
10,844 $74,000

Others Institutions Holding CRBP

About Corbus Pharmaceuticals Holdings, Inc.


  • Ticker CRBP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 125,268,000
  • Market Cap $2.19B
  • Description
  • Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an...
More about CRBP
Track This Portfolio

Track Voya Financial Advisors, Inc. Portfolio

Follow Voya Financial Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Financial Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Voya Financial Advisors, Inc. with notifications on news.